Division of Endocrinology and Metabolism, St. Joseph's Health Care London, London, Ontario, Canada
Department of Medicine, Western University, London, Ontario, Canada.
Diabetes Care. 2019 Jun;42(6):1018-1026. doi: 10.2337/dc18-2187. Epub 2019 Apr 22.
To determine if a structured transition program for young adults with type 1 diabetes improves clinic attendance, glycemic control, diabetes-related distress, quality of life, and satisfaction with care.
In this multicenter randomized controlled trial, young adults (17-20 years) with type 1 diabetes were randomly assigned to a transition program with a transition coordinator or to standard care. The intervention lasted 18 months (6 in pediatric and 12 in adult care). The primary outcome was the proportion of participants who failed to attend at least one adult diabetes clinic visit during the 12-month follow-up after completion of the intervention.
We randomized 205 participants, 104 to the transition program and 101 to standard care. Clinic attendance was improved in the transition program (mean [SD] number of visits 4.1 [1.1] vs. 3.6 [1.2], = 0.002), and there was greater satisfaction with care (mean [SD] score 29.0 [2.7] vs. 27.9 [3.4], = 0.032) and less diabetes-related distress (mean [SD] score 1.9 [0.8] vs. 2.1 [0.8], = 0.049) reported than in standard care. There was a trend toward improvement in mean HbA (8.33% [68 mmol/mol] vs. 8.80% [73 mmol/mol], = 0.057). During the 12-month follow-up, there was no difference in those failing to attend at least one clinic visit ( = 0.846), and the mean change in HbA did not differ between the groups ( = 0.073). At completion of follow-up, the groups did not differ with respect to satisfaction with care or diabetes-related distress and quality of life.
Transition support during this 18-month intervention was associated with increased clinic attendance, improved satisfaction with care, and decreased diabetes-related distress, but these benefits were not sustained 12 months after completion of the intervention.
确定针对 1 型糖尿病青年患者的结构化过渡计划是否能改善就诊情况、血糖控制、糖尿病相关困扰、生活质量和对护理的满意度。
在这项多中心随机对照试验中,17-20 岁的 1 型糖尿病青年患者被随机分配至过渡项目组(配有过渡协调员)或标准护理组。干预持续 18 个月(6 个月在儿科,12 个月在成人护理)。主要结局为干预完成后 12 个月随访期间未能至少参加一次成人糖尿病门诊就诊的参与者比例。
我们共随机分配了 205 名参与者,其中 104 名进入过渡项目组,101 名进入标准护理组。过渡项目组的就诊情况得到改善(平均[标准差]就诊次数 4.1[1.1] vs. 3.6[1.2], = 0.002),且对护理的满意度更高(平均[标准差]评分 29.0[2.7] vs. 27.9[3.4], = 0.032),糖尿病相关困扰更少(平均[标准差]评分 1.9[0.8] vs. 2.1[0.8], = 0.049),而标准护理组则相反。HbA 均值呈改善趋势(8.33%[68 mmol/mol] vs. 8.80%[73 mmol/mol], = 0.057)。在 12 个月的随访期间,未能至少参加一次门诊就诊的患者比例在两组间无差异( = 0.846),且两组间 HbA 的平均变化无差异( = 0.073)。随访结束时,两组在护理满意度或糖尿病相关困扰和生活质量方面无差异。
在这项为期 18 个月的干预中,过渡支持与就诊次数增加、护理满意度提高和糖尿病相关困扰减轻相关,但这些益处在干预完成后 12 个月并未持续。